Showing results (61-70 of 1,563) with videos related to
Sort By:
Pageof 157
Anticancer Research|November 1, 1984
Clinical evaluation of response or escape to chemotherapy and of survival of patients with multiple myeloma. A prospective study of 202 patients (1975-1982)R Bataille, P Souteyrand, J SanyEuropean Journal of Immunology|December 22, 1999
IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathwayD Puthier, R Bataille, M AmiotBlood|February 1, 1984
Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patientsR Bataille, J Grenier, J SanyLa Nouvelle Presse Medicale|February 14, 1981
[Apparently isolated plasmacytoma of bone. Clinical and prognostic data. 114 cases and review of literature (author's transl)]R Bataille, J Sany, H SerreBritish Journal of Haematology|July 1, 1995
Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivoR Bataille, D Chappard, M BasleCancer Investigation|January 1, 1988
In vitro production of beta 2 microglobulin by human myeloma cellsR Bataille, J Grenier, T CommesOncology|January 1, 1984
Polyclonal immunoglobulins in malignant plasma cell dyscrasiasR Bataille, P Dessauw, J SanyJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patientsR Bataille, C Legendre, J SanyAnticancer Research|May 1, 1987
Unexpected normal serum beta-microglobulin (B2M) levels in multiple myelomaR Bataille, J Grenier, J SanyPageof 157